Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.
Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.
复制标题
DOI:
10.1016/j.celrep.2021.110175
复制
发表时间:
2021-12-28
期刊:
影响因子:
8.8
通讯作者:
Horvath CM
中科院分区:
文献类型:
--
作者:
Lenoir JJ;Parisien JP;Horvath CM
Lysine 63-linked polyubiquitin (K63-Ub) chains activate a range of cellular immune and inflammatory signaling pathways, including the mammalian antiviral response. Interferon and antiviral genes are triggered by TRAF family ubiquitin ligases that form K63-Ub chains. LGP2 is a feedback inhibitor of TRAF-mediated K63-Ub that can interfere with diverse immune signaling pathways. Our results demonstrate that LGP2 inhibits K63-Ub by association with and sequestration of the K63-Ub-conjugating enzyme, Ubc13/UBE2N. The LGP2 helicase subdomain, Hel2i, mediates protein interaction that engages and inhibits Ubc13/UBE2N, affecting control over a range of K63-Ub ligase proteins, including TRAF6, TRIM25, and RNF125, all of which are inactivated by LGP2. These findings establish a unifying mechanism for LGP2-mediated negative regulation that can modulate a variety of K63-Ub signaling pathways. Lenoir et al. identify the mechanism that the immune regulatory protein, LGP2, uses to inhibit IRF3 and NF-κB activation. LGP2 blocks K63 polyubiquitination required for immune signaling by binding and sequestering the K63-conjugating enzyme, Ubc13/UBE2N, affecting a wide range of antiviral, cytokine, and immune signaling pathways.
登录
查看更多内容
影响因子:
5.4
作者:
Quicke KM;Diamond MS;Suthar MS
通讯作者:
Suthar MS
影响因子:
5.4
作者:
Komuro, Akihiko;Horvath, Curt M.
通讯作者:
Horvath, Curt M.
影响因子:
4.8
作者:
Bamming, Darja;Horvath, Curt M.
通讯作者:
Horvath, Curt M.
影响因子:
16
作者:
Ea, CK;Deng, L;Chen, ZJJ
通讯作者:
Chen, ZJJ
影响因子:
30.3
作者:
Isaacson MK;Ploegh HL
通讯作者:
Ploegh HL